Pittsburgh, PENNSYLVANIA2 Active Studies

Huntingtons Disease Clinical Trials in Pittsburgh, PENNSYLVANIA

Find 2 actively recruiting huntingtons disease clinical trials in Pittsburgh, PENNSYLVANIA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
600
Enrolling

Recruiting Huntingtons Disease Studies in Pittsburgh

About Huntingtons Disease Clinical Trials in Pittsburgh

Huntington's disease is an inherited condition that causes progressive degeneration of nerve cells in the brain, affecting movement, cognition, and behavior. It is caused by a mutation in the HTT gene. Current treatments manage symptoms, while gene-silencing therapies are being studied.

There are currently 2 huntingtons disease clinical trials recruiting participants in Pittsburgh, PENNSYLVANIA. These studies are seeking a combined 600 participants. Research is being sponsored by Daniel Coury, Children's Hospital Medical Center, Cincinnati. Clinical trial participation is free and participants receive study-related medical care at no cost.

Huntingtons Disease Clinical Trials in Pittsburgh — FAQ

Are there huntingtons disease clinical trials in Pittsburgh?

Yes, there are 2 huntingtons disease clinical trials currently recruiting in Pittsburgh, PENNSYLVANIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Pittsburgh?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Pittsburgh research site will contact you about next steps.

Are clinical trials in Pittsburgh free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Pittsburgh studies also compensate for your time and travel.

What huntingtons disease treatments are being tested?

The 2 active trials in Pittsburgh are testing new therapies including novel drugs, biologics, and treatment approaches for huntingtons disease.

Data updated March 2, 2026 from ClinicalTrials.gov